National Stroke Foundation

Xenical/Orlistat Capsules

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.


Approval Status:

Approved April 1999

Specific Treatments:


Therapeutic Areas

General Information

Xenical/Orlistat Capsules, 120 mg, a lipase inhibitor, have been approved for obesity management. Xenical acts by inhibiting the absorption of dietary fats.